GSP Crop Science Limited has formally announced the completion of the acquisition of the remaining 21% equity stake in its subsidiary, GSP Intermediates Private Limited (GIPL). This transaction involved the purchase of 31,50,000 equity shares, each with a face value of Rs. 10. As a result of this final acquisition, which concluded on June 11, 2026, GIPL has now become a wholly-owned subsidiary of GSP Crop Science Limited.

The acquisition represents a significant consolidation of GSP Crop Science Limited’s corporate structure, effectively moving from partial ownership to total control over GIPL. This strategic move follows a prior intimation regarding the planned acquisition shared by the company on May 14, 2026. The completion of this transaction ensures that the subsidiary is fully integrated into the operations of the parent company.

GSP Crop Science Limited is a research-driven agrochemical company that specializes in the development and manufacturing of a wide array of products including insecticides, herbicides, fungicides, and plant growth regulators. The company operates a robust business model with extensive product registrations and a strong commitment to R&D, holding numerous patents for its chemical innovations. In 2025, the company continued to focus on expanding its market presence and product portfolio, leveraging its significant manufacturing capabilities based in Gujarat to cater to both domestic and international markets.

In the 2025 financial period, GSP Crop Science demonstrated growth in its operational scale, though it faced competitive pressures typical of the agrochemical sector. The company’s revenue for the fiscal year ending March 2025 stood at approximately ₹1,287.3 Crores. While the company maintains a strong patent portfolio and an early-mover advantage in high-tech product segments, its financial performance in 2025 was influenced by the costs associated with its subsidiaries and the inherent volatility of the agrochemical market. Information regarding specific famous individual investors is not disclosed, though the company’s recent entry into the public markets via its 2026 IPO indicates a broad base of institutional and retail participation.